Baltimore Longitudinal Study Of Aging

$0Z01FY2002AGNIH

Aging

Investigators

Linked publications & trials

Paper 26732560 Paper 25934857 Paper 25614178 Paper 25378430 Paper 25078452 Paper 24982117 Paper 24636496 Paper 24436234 Paper 24362362 Paper 24262325 Paper 24218590 Paper 24021684 Paper 23929743 Paper 23625813 Paper 23569189 Paper 23381943 Paper 23362085 Paper 23041239 Paper 22941190 Paper 22564361 Paper 22421340 Paper 22417789 Paper 22384361 Paper 22363065 Paper 21940970 Paper 21873064 Paper 21803414 Paper 21743292 Paper 21614452 Paper 21601861 Paper 21544148 Paper 21320988 Paper 21300955 Paper 21208937 Paper 20967212 Paper 20869059 Paper 20800221 Paper 20736822 Paper 20634647 Paper 20511294 Paper 20485568 Paper 20477823 Paper 20305364 Paper 20159126 Paper 20128332 Paper 20126297 Paper 20080238 Paper 20008676 Paper 19884959 Paper 19850698 Paper 19751256 Paper 19738138 Paper 19662379 Paper 19651668 Paper 19646705 Paper 19448620 Paper 19414622 Paper 19307154 Paper 19262947 Paper 19199283 Paper 19196902 Paper 19196012 Paper 19126858 Paper 19126845 Paper 19054181 Paper 19038842 Paper 19038832 Paper 19028201 Paper 19023277 Paper 18929593 Paper 18922285 Paper 18845301 Paper 18809094 Paper 18707733 Paper 18693229 Paper 18692302 Paper 18662216 Paper 18614274 Paper 18593275 Paper 18559631 Paper 18512711 Paper 18492748 Paper 18456731 Paper 18431083 Paper 18230794 Paper 18065595 Paper 17991538 Paper 17595416 Paper 17499473 Paper 17481443 Paper 17347381 Paper 17341272 Paper 17222481 Paper 17097316 Paper 17077354 Paper 16817661 Paper 16720742 Paper 16608892 Paper 16037403 Paper 15798964

Abstract

The Baltimore Longitudinal Study of Aging (BLSA), the Intramural NIA's current major research program on human aging, has been conducted at the Gerontology Research Center since 1958. The study continues to represent a consortium of scientists who work to characterize normal and pathological aging. The BLSA consists of a series of longitudinal and cross-sectional studies oriented toward characterizing the human aging processes. The scientific goals include identifying age associated differences among individuals and changes in individuals over time; to characterize transitions from normal to pathological aging; to determine the relative contribution of aging, disease processes, cohort effects and secular effects; to expand the scientific understanding of predictors and risk factors for specific diseases and other end points and where possible to explore mechanisms for normal and/or pathological changes. The Acting Clinical Director is the current Director, BLSA; the Longitudinal Studies Scetion (LSS) and clinical support staff administer and manage the BLSA operations and the clinical evaluations of the research volunteers. A permanent new Director for the BLSA and Chief of the Longoitudinal Studies Section, Dr. Luigi Ferrucci, has been recruited and will be joing the NIA on September 26th of 2002. Current LSS scientists have continued to conduct research with the BLSA. The BLSA Executive Committee, an internally comprised committee of GRC scientists and the Director, BLSA, is responsible for oversight of BLSA operations and research directions. The total BLSA population as of 9/11/02 includes: Active (OS): 1438 (702 male, 736 female) Active (HV, TI): 542 (286 male, 256 female) Lost to F/U: 83 (39 male, 44 female) Withdrawn: 25 (16 male, 9 female) Deceased: 930 (773 male, 157 female) Total: 3018 (1816 male, 1202 female) [OS=On site; HV=Home Visits; TI=Telephone Interview; F/U=Follow up] Over the last year, 32% of all visits were by ethnic minorities with 24% of participants being of African-American descent. Between 10/1/01 and 9/11/02, 573 participants visited the GRC for the regular 2 to 2-1/2-day visit. This includes 26 new participants. A high priority remains systematic follow-up and, over the next year, evolution of the BLSA under the study's new director.

View original record on NIH RePORTER →